SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi
6
0
0
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Comparing Mechanical Power in Different Inspiratory Times
Role: collaborator
Can Novel Oxygenation Indices Guide the Diagnosis of Acute Respiratory Distress Syndrome
Role: collaborator
Can Shock Indices Be Prognostic Indicators in Sepsis/Septic Shock?
Role: collaborator
Benign Prostate Surgery and QOL and Sexual Function
Role: collaborator
Clinical Use of Stem Cells for the Treatment of Covid-19
Role: lead
A Proof of Concept Study for the DNA Repair Driven by the Mesenchymal Stem Cells in Critical COVID-19 Patients
Role: lead
All 6 trials loaded